Literature DB >> 9403698

Structure of the proteasome activator REGalpha (PA28alpha).

J R Knowlton1, S C Johnston, F G Whitby, C Realini, Z Zhang, M Rechsteiner, C P Hill.   

Abstract

The specificity of the 20S proteasome, which degrades many intracellular proteins, is regulated by protein complexes that bind to one or both ends of the cylindrical proteasome structure. One of these regulatory complexes, the 11S regulator (known as REG or PA28), stimulates proteasome peptidase activity and enhances the production of antigenic peptides for presentation by class I molecules of the major histocompatibility complex (MHC). The three REG subunits that have been identified, REGalpha, REGbeta and REGgamma (also known as the Ki antigen), share extensive sequence similarity, apart from a highly variable internal segment of 17-34 residues which may confer subunit-specific properties. REGalpha and REGbeta preferentially form a heteromeric complex, although purified REGalpha forms a heptamer in solution and has biochemical properties similar to the heteromeric REGalpha/REGbeta complex. We have now determined the crystal structure of human recombinant REGalpha at 2.8 A resolution. The heptameric barrel-shaped assembly contains a central channel that has an opening of 20 A diameter at one end and another of 30 A diameter at the presumed proteasome-binding surface. The binding of REG probably causes conformational changes that open a pore in the proteasome alpha-subunits through which substrates and products can pass.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9403698     DOI: 10.1038/37670

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  47 in total

Review 1.  The proteasome: a macromolecular assembly designed for controlled proteolysis.

Authors:  P Zwickl; D Voges; W Baumeister
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-09-29       Impact factor: 6.237

2.  Structural and functional characterization of the VirB5 protein from the type IV secretion system encoded by the conjugative plasmid pKM101.

Authors:  Hye-Jeong Yeo; Qing Yuan; Moriah R Beck; Christian Baron; Gabriel Waksman
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-12       Impact factor: 11.205

3.  Two-substrate association with the 20S proteasome at single-molecule level.

Authors:  Silke Hutschenreiter; Ali Tinazli; Kirstin Model; Robert Tampé
Journal:  EMBO J       Date:  2004-06-03       Impact factor: 11.598

4.  Blm10 protein promotes proteasomal substrate turnover by an active gating mechanism.

Authors:  Thomas Dange; David Smith; Tahel Noy; Philipp C Rommel; Lukas Jurzitza; Radames J B Cordero; Anne Legendre; Daniel Finley; Alfred L Goldberg; Marion Schmidt
Journal:  J Biol Chem       Date:  2011-10-24       Impact factor: 5.157

Review 5.  The ubiquitin-proteasome system.

Authors:  Dipankar Nandi; Pankaj Tahiliani; Anujith Kumar; Dilip Chandu
Journal:  J Biosci       Date:  2006-03       Impact factor: 1.826

6.  Structure of the Blm10-20 S proteasome complex by cryo-electron microscopy. Insights into the mechanism of activation of mature yeast proteasomes.

Authors:  Jack Iwanczyk; Kianoush Sadre-Bazzaz; Katherine Ferrell; Elena Kondrashkina; Timothy Formosa; Christopher P Hill; Joaquin Ortega
Journal:  J Mol Biol       Date:  2006-08-09       Impact factor: 5.469

7.  Lysine 188 substitutions convert the pattern of proteasome activation by REGgamma to that of REGs alpha and beta.

Authors:  J Li; X Gao; J Ortega; T Nazif; L Joss; M Bogyo; A C Steven; M Rechsteiner
Journal:  EMBO J       Date:  2001-07-02       Impact factor: 11.598

8.  Automated online sequential isotope labeling for protein quantitation applied to proteasome tissue-specific diversity.

Authors:  Reinout Raijmakers; Celia R Berkers; Annemieke de Jong; Huib Ovaa; Albert J R Heck; Shabaz Mohammed
Journal:  Mol Cell Proteomics       Date:  2008-06-04       Impact factor: 5.911

9.  Proteasome activator PA28gamma-dependent nuclear retention and degradation of hepatitis C virus core protein.

Authors:  Kohji Moriishi; Tamaki Okabayashi; Kousuke Nakai; Kyoji Moriya; Kazuhiko Koike; Shigeo Murata; Tomoki Chiba; Keiji Tanaka; Ryosuke Suzuki; Tetsuro Suzuki; Tatsuo Miyamura; Yoshiharu Matsuura
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

Review 10.  The ubiquitin-proteasome pathway in Huntington's disease.

Authors:  Steven Finkbeiner; Siddhartha Mitra
Journal:  ScientificWorldJournal       Date:  2008-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.